(Q51529126)

6 April 2018

title

Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk. (English)

1 reference

6 April 2018

author

Andrew Hayen

2

1 reference

6 April 2018

Kevin McGeechan

object named as

Kevin McGeechan

3

0 references

author name string

Katy Bell

1

1 reference

6 April 2018

Bruce Neal

4

1 reference

6 April 2018

Les Irwig

5

1 reference

6 April 2018

publication date

26 September 2011

1 reference

6 April 2018

European Journal of Preventive Cardiology

published in

1 reference

6 April 2018

volume

19

1 reference

6 April 2018

issue

6

1 reference

6 April 2018

page(s)

1474-1485

1 reference

6 April 2018

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Use of randomised trials to decide when to monitor response to new treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Mixed models showed no need for initial response monitoring after starting antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Monitoring cholesterol levels: measurement error or true change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study .

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Coronary artery calcium score and risk classification for coronary heart disease prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Coronary artery calcification screening: estimated radiation dose and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

The things to come of SHAPE: cost and effectiveness of cardiovascular prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

What makes a good predictor?: the evidence applied to coronary artery calcium score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

Lipid re-screening: what is the best measure and interval?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1741826711424494

21 January 2018

Identifiers

DOI

10.1177/1741826711424494

1 reference

6 April 2018

1 reference

6 April 2018